WallStreetZenWallStreetZen

NASDAQ: AVTX
Avalo Therapeutics Inc Stock Ownership - Who owns Avalo Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Avalo Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Garry Arthur NeilChief Executive Officer2025-03-2817,787$8.46
$150.48kSell
Christopher Ryan SullivanChief Financial Officer2025-03-287,285$8.46
$61.63kSell
June Sherie AlmenoffDirector2024-11-13500$13.00
$6.50kBuy
June Sherie AlmenoffDirector2024-11-12500$12.50
$6.25kBuy

1 of 1

AVTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVTX insiders and whales buy or sell their stock.

AVTX Shareholders

What type of owners hold Avalo Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC476.70%51,615,185$249.82MInsider
Robert Moscato Jr.82.68%8,952,643$43.33MInsider
Randal Jones58.74%6,359,900$30.78MInsider
Steven Boyd21.66%2,345,714$11.35MInsider
Patrick J. Crutcher15.10%1,634,771$7.91MInsider
Bvf Inc9.57%1,036,679$5.02MInstitution
Ra Capital Management LP8.93%967,000$4.68MInstitution
Orbimed Advisors LLC8.93%967,000$4.68MInstitution
Nantahala Capital Management LLC8.31%900,000$4.36MInstitution
Deep Track Capital LP7.94%859,876$4.16MInstitution

1 of 3

AVTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVTX9.22%90.78%Net SellingNet Selling
ONCY1.58%0.00%
ATRA17.07%82.93%Net BuyingNet Buying
MAIA4.87%16.62%Net BuyingNet Buying
CNTB5.09%0.00%
View Top Biotech Stocks

Avalo Therapeutics Stock Ownership FAQ

Who owns Avalo Therapeutics?

Avalo Therapeutics (NASDAQ: AVTX) is owned by 76.24% institutional shareholders, 750.42% Avalo Therapeutics insiders, and 0.00% retail investors. Armistice Capital LLC is the largest individual Avalo Therapeutics shareholder, owning 51.62M shares representing 476.70% of the company. Armistice Capital LLC's Avalo Therapeutics shares are currently valued at $249.82M.

If you're new to stock investing, here's how to buy Avalo Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.